HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Holger Stark Selected Research

Allergic Rhinitis

1/2021Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H4 receptor.
10/2011The histamine Hâ‚„ receptor: targeting inflammatory disorders.
10/2010Kojic acid derivatives as histamine H(3) receptor ligands.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Holger Stark Research Topics

Disease

20Inflammation (Inflammations)
04/2023 - 01/2009
15Neoplasms (Cancer)
03/2024 - 02/2012
13Alzheimer Disease (Alzheimer's Disease)
03/2024 - 05/2012
11Pain (Aches)
05/2023 - 10/2010
10Schizophrenia (Dementia Praecox)
03/2022 - 10/2002
10Parkinson Disease (Parkinson's Disease)
01/2021 - 10/2002
9Narcolepsy
06/2021 - 05/2012
8Neurodegenerative Diseases (Neurodegenerative Disease)
08/2023 - 10/2016
8Epilepsy (Aura)
01/2020 - 01/2016
7Pruritus (Itching)
02/2024 - 03/2009
6Neuralgia (Stump Neuralgia)
12/2023 - 11/2012
6Autistic Disorder (Autism)
07/2022 - 10/2019
5Atopic Dermatitis (Atopic Eczema)
04/2023 - 03/2009
5Autism Spectrum Disorder
12/2022 - 10/2019
4Immune System Diseases (Immune Disorders)
05/2023 - 11/2014
4Cognitive Dysfunction
01/2023 - 10/2016
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 10/2014
4Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 08/2016
4Asthma (Bronchial Asthma)
01/2021 - 10/2011
4Autoimmune Diseases (Autoimmune Disease)
09/2020 - 10/2011
4Seizures (Absence Seizure)
01/2020 - 06/2014
3Breast Neoplasms (Breast Cancer)
04/2023 - 08/2015
3Neuroinflammatory Diseases
02/2023 - 10/2019
3Obesity
01/2023 - 06/2017
3Psychotic Disorders (Schizoaffective Disorder)
03/2022 - 10/2002
3Multiple Sclerosis
01/2022 - 10/2014
3Memory Disorders (Memory Loss)
06/2021 - 01/2018
3Nervous System Diseases (Neurological Disorders)
04/2021 - 05/2012
3Allergic Rhinitis
01/2021 - 10/2010
3Dyskinesias (Dyskinesia)
01/2021 - 06/2003
3Disorders of Excessive Somnolence (Hypersomnia)
03/2019 - 11/2012
3Skin Diseases (Skin Disease)
11/2016 - 10/2009
3Hypersensitivity (Allergy)
01/2015 - 05/2005
2Brain Diseases (Brain Disorder)
07/2022 - 06/2021
2Mental Disorders (Mental Disorder)
03/2022 - 08/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 05/2017
2Prader-Willi Syndrome (Syndrome, Prader-Willi)
11/2020 - 03/2019
2Neuroblastoma
05/2020 - 01/2018
2Edema (Dropsy)
12/2018 - 08/2014
2Dermatitis
08/2016 - 01/2009
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2016 - 11/2014
2Relapsing-Remitting Multiple Sclerosis
01/2016 - 10/2014
2Fibrosis (Cirrhosis)
01/2016 - 11/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024

Drug/Important Bio-Agent (IBA)

32Histamine (Histamine Dihydrochloride)FDA Link
02/2024 - 05/2005
31LigandsIBA
03/2024 - 04/2005
18Histamine H3 Receptors (Histamine H3 Receptor)IBA
03/2023 - 07/2013
11Histamine H4 ReceptorsIBA
05/2023 - 01/2009
9Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2006
8Dopamine (Intropin)FDA LinkGeneric
07/2022 - 10/2002
6EnzymesIBA
08/2023 - 06/2013
6Neurotransmitter Agents (Neurotransmitter)IBA
12/2022 - 01/2020
6pitolisantIBA
01/2021 - 11/2012
5Monoamine Oxidase (MAO)IBA
06/2021 - 10/2017
5Fingolimod Hydrochloride (FTY720)FDA Link
01/2021 - 10/2014
4Analgesics (Analgesic Drugs)IBA
05/2023 - 01/2018
4Cholinesterases (Cholinesterase)IBA
01/2023 - 10/2017
4Acetylcholine (Acetylcholine Chloride)FDA Link
06/2021 - 10/2019
4Anticonvulsants (Antiepileptic Drugs)IBA
01/2020 - 01/2016
41- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
12/2018 - 01/2009
3CeramidesIBA
09/2023 - 02/2012
3CarrageenanIBA
05/2023 - 08/2014
3Histamine Receptors (Histamine Receptor)IBA
04/2023 - 12/2015
3N4- (2,6- dichlorobenzyl)- 6- (4- methylpiperazin- 1- yl)pyrimidine- 2,4- diamineIBA
09/2022 - 12/2015
3Sphingosine-1-Phosphate ReceptorsIBA
01/2022 - 06/2015
3Levodopa (L Dopa)FDA LinkGeneric
01/2021 - 06/2003
3EsterasesIBA
06/2020 - 10/2019
3imidazoleIBA
04/2020 - 01/2018
3Pentylenetetrazole (Metrazol)IBA
01/2020 - 01/2018
3Cytochrome P-450 CYP3AIBA
06/2019 - 08/2014
3CytokinesIBA
08/2016 - 03/2009
2dihydroceramide desaturaseIBA
09/2023 - 01/2022
2LipidsIBA
09/2023 - 09/2014
2piperidineIBA
01/2023 - 01/2021
2Dopamine D3 ReceptorsIBA
01/2023 - 06/2003
2Serotonin (5 Hydroxytryptamine)IBA
03/2022 - 02/2022
2cariprazineIBA
03/2022 - 01/2018
2AntioxidantsIBA
02/2022 - 01/2018
2siponimodIBA
01/2022 - 09/2020
2Retinaldehyde (Retinal)IBA
01/2022 - 01/2006
2Scopolamine (Hyoscine)FDA Link
06/2021 - 01/2018
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021 - 01/2017
2GTP-Binding Proteins (G-Protein)IBA
11/2020 - 01/2018
2Therapeutic UsesIBA
11/2020 - 06/2003
2Valproic Acid (Depakote)FDA LinkGeneric
06/2020 - 10/2019
2ciproxifanIBA
02/2019 - 11/2012
2Formaldehyde (Formol)FDA Link
01/2019 - 01/2018
2ChemokinesIBA
06/2018 - 01/2015
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 - 08/2016
2Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2017 - 01/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016 - 11/2014
27a- (4- octylphenethyl)tetrahydro- 1H- oxazolo(3,4- c)oxazoleIBA
01/2016 - 10/2014
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2016 - 11/2014
2CollagenIBA
01/2016 - 11/2014
2Arachidonic Acid (Vitamin F)IBA
01/2015 - 09/2014
2LeukotrienesIBA
01/2015 - 09/2014
2Messenger RNA (mRNA)IBA
01/2015 - 03/2009

Therapy/Procedure

14Therapeutics
03/2024 - 06/2003
2Cell Transplantation
01/2022 - 05/2017
2Immunotherapy
01/2022 - 05/2017